Publication | Closed Access

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

Tumor BiologyAdvanced Breast CancerSystems BiologyBreast OncologyC-erbb-2 ExpressionMedicineSequential MethotrexateCancer BiologyBreast CancerCancer TreatmentCancer GeneticsRadiation OncologyOncologyCell BiologyMolecular Oncology